Gut Microbiota as a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents

Hormone and Metabolic Research

Volumn 48, Issue 6, 2016, Pages 349-358

  Ejtahed, H S ^a   Soroush, A R ^a   Angoorani, P ^a   Larijani, B ^b   Hasani Ranjbar, S ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

diabetes; gut microbiota; obesity; osteoporosis

Indexed keywords

ANIMAL; DIABETES MELLITUS; HUMAN; INTESTINE FLORA; METABOLIC DISEASES; MICROBIOLOGY; OBESITY; OSTEOPOROSIS;

ANIMALS; DIABETES MELLITUS; GASTROINTESTINAL MICROBIOME; HUMANS; METABOLIC DISEASES; OBESITY; OSTEOPOROSIS;

EID: 84970021164     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0042-107792     Document Type: Review

References (126)

1. Brahe L. K., Le Chatelier E., Prifti E., Pons N., Kennedy S., Hansen T., Pedersen O., Astrup A., Ehrlich S. D., Larsen L. H. Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutr Diabetes: 2015; 5 e159
2. Mohammed A., Guda C. Application of a hierarchical enzyme classification method reveals the role of gut microbiome in human metabolism. BMC Genomics: 2015; 16 07 S16
3. Tremaroli V., Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature: 2012; 489 242 249
4. Vijay-Kumar M., Aitken J. D., Carvalho F. A., Cullender T. C., Mwangi S., Srinivasan S., Sitaraman S. V., Knight R., Ley R. E., Gewirtz A. T. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science: 2010; 328 228 231
5. Larsen N., Vogensen F. K., van den Berg F. W., Nielsen D. S., Andreasen A. S., Pedersen B. K., Al-Soud W. A., Sorensen S. J., Hansen L. H., Jakobsen M. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One: 2010; 5 e9085
6. Sjogren K., Engdahl C., Henning P., Lerner U. H., Tremaroli V., Lagerquist M. K., Backhed F., Ohlsson C. The gut microbiota regulates bone mass in mice. J Bone Miner Res: 2012; 27 1357 1367
7. Sharma P., Kumari H., Kumar M., Verma M., Kumari K., Malhotra S., Khurana J., Lal R. From bacterial genomics to metagenomics: concept, tools and recent advances. Indian J Microbiol: 2008; 48 173 194
8. Kim B. S., Jeon Y. S., Chun J. Current status and future promise of the human microbiome. Pediatr Gastroenterol Hepatol Nutr: 2013; 16 71 79
9. Kau A. L., Ahern P. P., Griffin N. W., Goodman A. L., Gordon J. I. Human nutrition, the gut microbiome and the immune system. Nature: 2011; 474 327 336
10. World Health Organization Obesity and overweight - Fact sheet N-311-updated March 2011. http://www.who.int/mediacentre/factsheets/fs311/en/index.html
11. Jafari-Adli S., Jouyandeh Z., Qorbani M., Soroush A., Larijani B., Hasani-Ranjbar S. Prevalence of obesity and overweight in adults and children in Iran; a systematic review. J Diabetes Metab Disord: 2014; 13 121
12. Tabatabaei-Malazy O., Hasani-Ranjbar S., Amoli M. M., Heshmat R., Sajadi M., Derakhshan R., Amiri P., Namakchian M., Rezazadeh E., Tavakkoly-Bazzaz J., Keshtkar A., Larijani B. Gender-specific differences in the association of adiponectin gene polymorphisms with body mass index. Rev Diabet Stud: 2010; 7 241 246
13. Tavakkoly Bazzaz J., Shojapoor M., Nazem H., Amiri P., Fakhrzadeh H., Heshmat R., Parvizi M., Hasani Ranjbar S., Amoli M. M. Methylenetetrahydrofolate reductase gene polymorphism in diabetes and obesity. Mol Biol Rep: 2010; 37 105 109
14. Ramdas M., Harel C., Armoni M., Karnieli E. AHNAK KO mice are protected from diet-induced obesity but are glucose intolerant. Horm Metab Res: 2015; 47 265 272
15. Martins C. J., Genelhu V., Di Marzo V., Francischetti E. A. The endocannabinoid system - back to the scene of cardiometabolic risk factors control? Horm Metab Res: 2014; 46 529 536
16. Lv J., Pan Y., Li X., Cheng D., Ju H., Tian J., Shi H., Zhang Y. Study on the distribution and elimination of the new hormone irisin in vivo: new discoveries regarding irisin. Horm Metab Res: 2015; 47 591 595
17. Almario R. U., Karakas S. E. Roles of circulating WNT-signaling proteins and WNT-inhibitors in human adiposity, insulin resistance, insulin secretion, and inflammation. Horm Metab Res: 2015; 47 152 157
18. Moreno-Indias I., Cardona F., Tinahones F. J., Queipo-Ortuno M. I. Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol: 2014; 5 190
19. Turnbaugh P. J., Ley R. E., Mahowald M. A., Magrini V., Mardis E. R., Gordon J. I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature: 2006; 444 1027 1031
20. Ley R. E., Backhed F., Turnbaugh P., Lozupone C. A., Knight R. D., Gordon J. I. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA: 2005; 102 11070 11075
21. Heimann E., Nyman M., Degerman E. Propionic acid and butyric acid inhibit lipolysis and de novo lipogenesis and increase insulin-stimulated glucose uptake in primary rat adipocytes. Adipocyte: 2015; 4 81 88
22. Chimerel C., Emery E., Summers D. K., Keyser U., Gribble F. M., Reimann F. Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell Rep: 2014; 9 1202 1208
23. Benson A. K., Kelly S. A., Legge R., Ma F., Low S. J., Kim J., Zhang M., Oh P. L., Nehrenberg D., Hua K., Kachman S. D., Moriyama E. N., Walter J., Peterson D. A., Pomp D. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci U S A: 2010; 107 18933 18938
24. The Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome. Nature: 2012; 486 207 214
25. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D. R., Fernandes G. R., Tap J., Bruls T., Batto J. M., Bertalan M., Borruel N., Casellas F., Fernandez L., Gautier L., Hansen T., Hattori M., Hayashi T., Kleerebezem M., Kurokawa K., Leclerc M., Levenez F., Manichanh C., Nielsen H. B., Nielsen T., Pons N., Poulain J., Qin J., Sicheritz-Ponten T., Tims S., Torrents D., Ugarte E., Zoetendal E. G., Wang J., Guarner F., Pedersen O., de Vos W. M., Brunak S., Dore J., Antolin M., Artiguenave F., Blottiere H. M., Almeida M., Brechot C., Cara C., Chervaux C., Cultrone A., Delorme C., Denariaz G., Dervyn R., Foerstner K. U., Friss C., van de Guchte M., Guedon E., Haimet F., Huber W., van Hylckama-Vlieg J., Jamet A., Juste C., Kaci G., Knol J., Lakhdari O., Layec S., Le Roux K., Maguin E., Merieux A., Melo Minardi R., M'Rini C., Muller J., Oozeer R., Parkhill J., Renault P., Rescigno M., Sanchez N., Sunagawa S., Torrejon A., Turner K., Vandemeulebrouck G., Varela E., Winogradsky Y., Zeller G., Weissenbach J., Ehrlich S. D., Bork P. Enterotypes of the human gut microbiome. Nature: 2011; 473 174 180
26. Turnbaugh P. J., Ridaura V. K., Faith J. J., Rey F. E., Knight R., Gordon J. I. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med: 2009; 1 6ra14
27. Turnbaugh P. J., Hamady M., Yatsunenko T., Cantarel B. L., Duncan A., Ley R. E., Sogin M. L., Jones W. J., Roe B. A., Affourtit J. P., Egholm M., Henrissat B., Heath A. C., Knight R., Gordon J. I. A core gut microbiome in obese and lean twins. Nature: 2009; 457 480 484
28. Ley R. E., Turnbaugh P. J., Klein S., Gordon J. I. Microbial ecology: human gut microbes associated with obesity. Nature: 2006; 444 1022 1023
29. Armougom F., Henry M., Vialettes B., Raccah D., Raoult D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS One: 2009; 4 e7125
30. Collado M. C., Isolauri E., Laitinen K., Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr: 2008; 88 894 899
31. Furet J. P., Kong L. C., Tap J., Poitou C., Basdevant A., Bouillot J. L., Mariat D., Corthier G., Dore J., Henegar C., Rizkalla S., Clement K. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes: 2010; 59 3049 3057
32. Duncan S. H., Lobley G. E., Holtrop G., Ince J., Johnstone A. M., Louis P., Flint H. J. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond): 2008; 32 1720 1724
33. Jumpertz R., Le D. S., Turnbaugh P. J., Trinidad C., Bogardus C., Gordon J. I., Krakoff J. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr: 2011; 94 58 65
34. Mai V., McCrary Q. M., Sinha R., Glei M. Associations between dietary habits and body mass index with gut microbiota composition and fecal water genotoxicity: an observational study in African American and Caucasian American volunteers. Nutr J: 2009; 8 49
35. Kocelak P., Zak-Golab A., Zahorska-Markiewicz B., Aptekorz M., Zientara M., Martirosian G., Chudek J., Olszanecka-Glinianowicz M. Resting energy expenditure and gut microbiota in obese and normal weight subjects. Eur Rev Med Pharmacol Sci: 2013; 17 2816 2821
36. Borgo F., Verduci E., Riva A., Lassandro C., Riva E., Morace G., Borghi E. Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study. Child Obes: 2016; Mar 23 [Epub ahead of print]
37. Million M., Maraninchi M., Henry M., Armougom F., Richet H., Carrieri P., Valero R., Raccah D., Vialettes B., Raoult D. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes (Lond): 2012; 36 817 825
38. Drissi F., Merhej V., Angelakis E., El Kaoutari A., Carriere F., Henrissat B., Raoult D. Comparative genomics analysis of Lactobacillus species associated with weight gain or weight protection. Nutr Diabetes: 2014; 4 e109
39. Lim S. M., Jeong J. J., Woo K. H., Han M. J., Kim D. H. Lactobacillus sakei OK67 ameliorates high-fat diet-induced blood glucose intolerance and obesity in mice by inhibiting gut microbiota lipopolysaccharide production and inducing colon tight junction protein expression. Nutr Res: 2016; 36 337 348
40. Everard A., Belzer C., Geurts L., Ouwerkerk J. P., Druart C., Bindels L. B., Guiot Y., Derrien M., Muccioli G. G., Delzenne N. M., de Vos W. M., Cani P. D. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A: 2013; 110 9066 9071
41. Walters W. A., Xu Z., Knight R. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett: 2014; 588 4223 4233
42. Al-Ghalith G. A., Vangay P., Knights D. The guts of obesity: progress and challenges in linking gut microbes to obesity. Discov Med: 2015; 19 81 88
43. Guida S., Venema K. Gut microbiota and obesity: involvement of the adipose tissue. J Funct Foods: 2015; 14 407 423
44. Olli K., Salli K., Alhoniemi E., Saarinen M., Ibarra A., Vasankari T., Rautonen N., Tiihonen K. Postprandial effects of polydextrose on satiety hormone responses and subjective feelings of appetite in obese participants. Nutr J: 2015; 14 2
45. Rosenbaum M., Knight R., Leibel R. The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol Metab: 2015; 26 493 501
46. Kimura I., Inoue D., Hirano K., Tsujimoto G. The SCFA Receptor GPR43 and Energy Metabolism. Front Endocrinol (Lausanne): 2014; 5 85
47. Inoue D., Tsujimoto G., Kimura I. Regulation of Energy Homeostasis by GPR41. Front Endocrinol (Lausanne): 2014; 5 81
48. Backhed F., Ding H., Wang T., Hooper L. V., Koh G. Y., Nagy A., Semenkovich C. F., Gordon J. I. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA: 2004; 101 15718 15723
49. Schele E., Grahnemo L., Anesten F., Hallen A., Backhed F., Jansson J. O. The gut microbiota reduces leptin sensitivity and the expression of the obesity-suppressing neuropeptides proglucagon (Gcg) and brain-derived neurotrophic factor (Bdnf) in the central nervous system. Endocrinology: 2013; 154 3643 3651
50. Everard A., Cani P. D. Gut microbiota and GLP-1. Rev Endocr Metab Disord: 2014; 15 189 196
51. Everard A., Lazarevic V., Derrien M., Girard M., Muccioli G. G., Neyrinck A. M., Possemiers S., Van Holle A., Francois P., de Vos W. M., Delzenne N. M., Schrenzel J., Cani P. D. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes: 2011; 60 2775 2786
52. Cani P. D., Amar J., Iglesias M. A., Poggi M., Knauf C., Bastelica D., Neyrinck A. M., Fava F., Tuohy K. M., Chabo C., Waget A., Delmee E., Cousin B., Sulpice T., Chamontin B., Ferrieres J., Tanti J. F., Gibson G. R., Casteilla L., Delzenne N. M., Alessi M. C., Burcelin R. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes: 2007; 56 1761 1772
53. Requena T., Cotter P., Shahar D. R., Kleiveland C. R., Martinez-Cuesta M. C., Pelaez C., Lea T. Interactions between gut microbiota, food and the obese host. Trends Food Sci Technol: 2013; 34 44 53
54. Backhed F., Manchester J. K., Semenkovich C. F., Gordon J. I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA: 2007; 104 979 984
55. Delgado S., Suarez A., Mayo B. Bifidobacterial diversity determined by culturing and by 16S rDNA sequence analysis in feces and mucosa from ten healthy Spanish adults. Dig Dis Sci: 2006; 51 1878 1885
56. Mayorga Reyes L., Gonzalez Vazquez R., Cruz Arroyo S. M., Melendez Avalos A., Reyes Castillo P. A., Chavaro Perez D. A., Ramos Terrones I., Ramos Ibanez N., Rodriguez Magallanes M. M., Langella P., Bermudez Humaran L., Azaola Espinosa A. Correlation between diet and gut bacteria in a population of young adults. Int J Food Sci Nutr: 2016; 1 9
57. Zhang C., Zhang M., Wang S., Han R., Cao Y., Hua W., Mao Y., Zhang X., Pang X., Wei C., Zhao G., Chen Y., Zhao L. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J: 2010; 4 232 241
58. Hill C., Guarner F., Reid G., Gibson G. R., Merenstein D. J., Pot B., Morelli L., Canani R. B., Flint H. J., Salminen S., Calder P. C., Sanders M. E. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Astroenterol Hepatol: 2014; 11 506 514
59. Kochan P., Chmielarczyk A., Szymaniak L., Brykczynski M., Galant K., Zych A., Pakosz K., Giedrys-Kalemba S., Lenouvel E., Heczko P. B. Lactobacillus rhamnosus administration causes sepsis in a cardiosurgical patient - is the time right to revise probiotic safety guidelines? Clin Microbiol Infect: 2011; 17 1589 1592
60. Gibson G. R., Scott K. P., Rastall R. A., Tuohy K. M., Hotchkiss A., Dubert-Ferrandon A., Gareau M., Murphy E. F., Saulnier D., Loh G., Macfarlane S., Delzenne N., Ringel Y., Kozianowski G., Dickmann R., Lenoir-Wijnkoop I., Walker C., Buddington R. Dietary prebiotics: current status and new definition. Food Sci Technol Bull Funct Foods: 2010; 7 1 19
61. Cani P. D., Delzenne N. M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des: 2009; 15 1546 1558
62. Monteagudo-Mera A., Arthur J. C., Jobin C., Keku T., Bruno-Barcena J. M., Azcarate-Peril M. A. High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome. Benef Microbes: 2016; 1 18
63. Cani P. D., Lecourt E., Dewulf E. M., Sohet F. M., Pachikian B. D., Naslain D., De Backer F., Neyrinck A. M., Delzenne N. M. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr: 2009; 90 1236 1243
64. Cani P. D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., Geurts L., Naslain D., Neyrinck A., Lambert D. M., Muccioli G. G., Delzenne N. M. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut: 2009; 58 1091 1103
65. Meyer D. Health benefits of prebiotic fibers. Adv Food Nutr Res: 2015; 74 47 91
66. Konturek P. C., Haziri D., Brzozowski T., Hess T., Heyman S., Kwiecien S., Konturek S. J., Koziel J. Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases. J Physiol Pharmacol: 2015; 66 483 491
67. Vrieze A., Van Nood E., Holleman F., Salojarvi J., Kootte R. S., Bartelsman J. F., Dallinga-Thie G. M., Ackermans M. T., Serlie M. J., Oozeer R., Derrien M., Druesne A., Van Hylckama Vlieg J. E., Bloks V. W., Groen A. K., Heilig H. G., Zoetendal E. G., Stroes E. S., de Vos W. M., Hoekstra J. B., Nieuwdorp M. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology: 2012; 143 913.e7 916.e7
68. Clemente J. C., Ursell L. K., Parfrey L. W., Knight R. The impact of the gut microbiota on human health: an integrative view. Cell: 2012; 148 1258 1270
69. Biagi E., Nylund L., Candela M., Ostan R., Bucci L., Pini E., Nikkila J., Monti D., Satokari R., Franceschi C., Brigidi P., De Vos W. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One: 2010; 5 e10667
70. Cardwell C. R., Stene L. C., Joner G., Cinek O., Svensson J., Goldacre M. J., Parslow R. C., Pozzilli P., Brigis G., Stoyanov D., Urbonaite B., Sipetic S., Schober E., Ionescu-Tirgoviste C., Devoti G., de Beaufort C. E., Buschard K., Patterson C. C. Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia: 2008; 51 726 735
71. Vehik K., Dabelea D. Why are C-section deliveries linked to childhood type 1 diabetes? Diabetes: 2012; 61 36 37
72. Davis-Richardson A. G., Ardissone A. N., Dias R., Simell V., Leonard M. T., Kemppainen K. M., Drew J. C., Schatz D., Atkinson M. A., Kolaczkowski B., Ilonen J., Knip M., Toppari J., Nurminen N., Hyoty H., Veijola R., Simell T., Mykkanen J., Simell O., Triplett E. W. Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. Front Microbiol: 2014; 5 678
73. Chassaing B., Koren O., Goodrich J. K., Poole A. C., Srinivasan S., Ley R. E., Gewirtz A. T. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature: 2015; 519 92 96
74. Suez J., Korem T., Zeevi D., Zilberman-Schapira G., Thaiss C. A., Maza O., Israeli D., Zmora N., Gilad S., Weinberger A., Kuperman Y., Harmelin A., Kolodkin-Gal I., Shapiro H., Halpern Z., Segal E., Elinav E. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature: 2014; 514 181 186
75. Turnbaugh P. J., Backhed F., Fulton L., Gordon J. I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe: 2008; 3 213 223
76. Karlsson F. H., Tremaroli V., Nookaew I., Bergstrom G., Behre C. J., Fagerberg B., Nielsen J., Backhed F. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature: 2013; 498 99 103
77. Sato J., Kanazawa A., Ikeda F., Yoshihara T., Goto H., Abe H., Komiya K., Kawaguchi M., Shimizu T., Ogihara T., Tamura Y., Sakurai Y., Yamamoto R., Mita T., Fujitani Y., Fukuda H., Nomoto K., Takahashi T., Asahara T., Hirose T., Nagata S., Yamashiro Y., Watada H. Gut dysbiosis and detection of live gut bacteria in blood of Japanese patients with type 2 diabetes. Diabetes Care: 2014; 37 2343 2350
78. Schwiertz A., Taras D., Schafer K., Beijer S., Bos N. A., Donus C., Hardt P. D. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring): 2010; 18 190 195
79. Zhang X., Shen D., Fang Z., Jie Z., Qiu X., Zhang C., Chen Y., Ji L. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One: 2013; 8 e71108
80. Cani P. D., Knauf C., Iglesias M. A., Drucker D. J., Delzenne N. M., Burcelin R. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes: 2006; 55 1484 1490
81. De Angelis M., Montemurno E., Vannini L., Cosola C., Cavallo N., Gozzi G., Maranzano V., Di Cagno R., Gobbetti M., Gesualdo L. Effect of Whole-Grain Barley on the Human Fecal Microbiota and Metabolome. Appl Environ Microbiol: 2015; 81 7945 7956
82. Tazoe H., Otomo Y., Kaji I., Tanaka R., Karaki S. I., Kuwahara A. Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J Physiol Pharmacol: 2008; 59 02 251 262
83. Kimura I., Ozawa K., Inoue D., Imamura T., Kimura K., Maeda T., Terasawa K., Kashihara D., Hirano K., Tani T., Takahashi T., Miyauchi S., Shioi G., Inoue H., Tsujimoto G. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun: 2013; 4 1829
84. Oh D. Y., Lagakos W. S. The role of G-protein-coupled receptors in mediating the effect of fatty acids on inflammation and insulin sensitivity. Curr Opin Clin Nutr Metab Care: 2011; 14 322 327
85. Esser N., Legrand-Poels S., Piette J., Scheen A. J., Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract: 2014; 105 141 150
86. Yassour M., Lim M. Y., Yun H. S., Tickle T. L., Sung J., Song Y. M., Lee K., Franzosa E. A., Morgan X. C., Gevers D., Lander E. S., Xavier R. J., Birren B. W., Ko G., Huttenhower C. Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes. Genome Med: 2016; 8 17
87. Shoelson S. E., Lee J., Goldfine A. B. Inflammation and insulin resistance. J Clin Invest: 2006; 116 1793 1801
88. Cani P. D., Bibiloni R., Knauf C., Waget A., Neyrinck A. M., Delzenne N. M., Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes: 2008; 57 1470 1481
89. De Vadder F., Kovatcheva-Datchary P., Goncalves D., Vinera J., Zitoun C., Duchampt A., Backhed F., Mithieux G. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell: 2014; 156 84 96
90. Delaere F., Duchampt A., Mounien L., Seyer P., Duraffourd C., Zitoun C., Thorens B., Mithieux G. The role of sodium-coupled glucose co-transporter 3 in the satiety effect of portal glucose sensing. Mol Metab: 2012; 2 47 53
91. Ejtahed H. S., Mohtadi-Nia J., Homayouni-Rad A., Niafar M., Asghari-Jafarabadi M., Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition: 2012; 28 539 543
92. Ejtahed H. S., Mohtadi-Nia J., Homayouni-Rad A., Niafar M., Asghari-Jafarabadi M., Mofid V., Akbarian-Moghari A. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci: 2011; 94 3288 3294
93. Prasad J., Gill H. S., Smart J. B., Gopal P. K. Selection and characterization of Lactobacillus and Bifidobacterium strains for use as probiotics. Int Dairy J: 1998; 8 993 1002
94. Yadav H., Jain S., Sinha P. R. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition: 2007; 23 62 68
95. Andersson U., Branning C., Ahrne S., Molin G., Alenfall J., Onning G., Nyman M., Holm C. Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse. Benef Microbes: 2010; 1 189 196
96. Marques T. M., Patterson E., Wall R., O'Sullivan O., Fitzgerald G. F., Cotter P. D., Dinan T. G., Cryan J. F., Ross R. P., Stanton C. Influence of GABA and GABA-producing Lactobacillus brevis DPC 6108 on the development of diabetes in a streptozotocin rat model. Benef Microbes: 2016; 1 12
97. Pickup J. C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care: 2004; 27 813 823
98. Razmpoosh E., Javadi M., Ejtahed H. S., Mirmiran P. Probiotics as beneficial agents in the management of diabetes mellitus: a systematic review. Diabetes Metab Res Rev: 2016; 32 143 168
99. Cani P. D., Neyrinck A. M., Fava F., Knauf C., Burcelin R. G., Tuohy K. M., Gibson G. R., Delzenne N. M. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia: 2007; 50 2374 2383
100. Shin N. R., Lee J. C., Lee H. Y., Kim M. S., Whon T. W., Lee M. S., Bae J. W. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut: 2014; 63 727 735
101. Yin Y. Y., Liu Y. J., Zhu W. Y., Mao S. Y. Effects of Acarbose Addition on Ruminal Bacterial Microbiota, Lipopolysaccharide Levels and Fermentation Characteristics In vitro. Asian-Australas J Anim Sci: 2014; 27 1726 1735
102. Sambrook P., Cooper C. Osteoporosis. Lancet: 2006; 367 2010 2018
103. Ralston S. H., Uitterlinden A. G. Genetics of osteoporosis. Endocr Rev: 2010; 31 629 662
104. Maynard C. L., Elson C. O., Hatton R. D., Weaver C. T. Reciprocal interactions of the intestinal microbiota and immune system. Nature: 2012; 489 231 241
105. Goulet O. Potential role of the intestinal microbiota in programming health and disease. Nutr Rev: 2015; 73 01 32 40
106. Schmidt S., Mellstrom D., Norjavaara E., Sundh V., Saalman R. Longitudinal assessment of bone mineral density in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr: 2012; 55 511 518
107. Lorenzo J., Horowitz M., Choi Y. Osteoimmunology: interactions of the bone and immune system. Endocr Rev: 2008; 29 403 440
108. Ohlsson C., Sjogren K. Effects of the gut microbiota on bone mass. Trends Endocrinol Metab: 2015; 26 69 74
109. Inglis J. E., Ilich J. Z. The Microbiome and Osteosarcopenic Obesity in Older Individuals in Long-Term Care Facilities. Curr Osteoporos Rep: 2015; 13 358 362
110. van Tongeren S. P., Slaets J. P., Harmsen H. J., Welling G. W. Fecal microbiota composition and frailty. Appl Environ Microbiol: 2005; 71 6438 6442
111. Claesson M. J., Jeffery I. B., Conde S., Power S. E., O'Connor E. M., Cusack S., Harris H. M., Coakley M., Lakshminarayanan B., O'Sullivan O., Fitzgerald G. F., Deane J., O'Connor M., Harnedy N., O'Connor K., O'Mahony D., van Sinderen D., Wallace M., Brennan L., Stanton C., Marchesi J. R., Fitzgerald A. P., Shanahan F., Hill C., Ross R. P., O'Toole P. W. Gut microbiota composition correlates with diet and health in the elderly. Nature: 2012; 488 178 184
112. Charles J. F., Ermann J., Aliprantis A. O. The intestinal microbiome and skeletal fitness: Connecting bugs and bones. Clin Immunol: 2015; 159 163 169
113. Weaver C. M., Martin B. R., Nakatsu C. H., Armstrong A. P., Clavijo A., McCabe L. D., McCabe G. P., Duignan S., Schoterman M. H., van den Heuvel E. G. Galactooligosaccharides improve mineral absorption and bone properties in growing rats through gut fermentation. J Agric Food Chem: 2011; 59 6501 6510
114. Clarke G., Stilling R. M., Kennedy P. J., Stanton C., Cryan J. F., Dinan T. G. Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol: 2014; 28 1221 1238
115. Reigstad C. S., Salmonson C. E., Rainey J. F. 3rd, Szurszewski J. H., Linden D. R., Sonnenburg J. L., Farrugia G., Kashyap P. C. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J: 2015; 29 1395 1403
116. Yano J. M., Yu K., Donaldson G. P., Shastri G. G., Ann P., Ma L., Nagler C. R., Ismagilov R. F., Mazmanian S. K., Hsiao E. Y. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell: 2015; 161 264 276
117. Scholz-Ahrens K. E., Schaafsma G., van den Heuvel E. G., Schrezenmeir J. Effects of prebiotics on mineral metabolism. Am J Clin Nutr: 2001; 73 2 Suppl 459s 464s
118. Britton R. A., Irwin R., Quach D., Schaefer L., Zhang J., Lee T., Parameswaran N., McCabe L. R. Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol: 2014; 229 1822 1830
119. Ohlsson C., Engdahl C., Fak F., Andersson A., Windahl S. H., Farman H. H., Moverare-Skrtic S., Islander U., Sjogren K. Probiotics protect mice from ovariectomy-induced cortical bone loss. PLoS One: 2014; 9 e92368
120. McCabe L. R., Irwin R., Schaefer L., Britton R. A. Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice. J Cell Physiol: 2013; 228 1793 1798
121. Zhang J., Motyl K. J., Irwin R., MacDougald O. A., Britton R. A., McCabe L. R. Loss of bone and Wnt10b expression in male type 1 diabetic mice is blocked by the probiotic L. reuteri. Endocrinology: 2015; En20151308
122. Rodrigues F. C., Castro A. S., Rodrigues V. C., Fernandes S. A., Fontes E. A., de Oliveira T. T., Martino H. S., de Luces Fortes Ferreira C. L. Yacon flour and Bifidobacterium longum modulate bone health in rats. J Med Food: 2012; 15 664 670
123. Hasani-Ranjbar S., Jouyandeh Z., Abdollahi M. A systematic review of anti-obesity medicinal plants - an update. J Diabetes Metab Disord: 2013; 12 28
124. Hasani-Ranjbar S., Larijani B. Medicinal plants as potential new target drugs in endocrine disorders - Review article. Iran J Public Health: 2014; 43 01 24 34
125. Hasani-Ranjbar S., Nayebi N., Larijani B., Abdollahi M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J Gastroenterol: 2009; 15 3073 3085
126. Neef A., Sanz Y. Future for probiotic science in functional food and dietary supplement development. Curr Opin Clin Nutr Metab Care: 2013; 16 679 687